68Ga-RGD

DRUG3 trials

Sponsors

Peking Union Medical College Hospital

Conditions

Brain TumorBreast CancerKeloidLung NeoplasmsPET/CT ImagingProstate Cancer

Early Phase 1

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

RecruitingNCT05543954

Peking Union Medical College HospitalLung Neoplasms

Start: 2022-09-03End: 2025-12-31Target: 60Updated: 2024-07-05

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

RecruitingNCT05549024

Peking Union Medical College HospitalBrain Tumor, Breast Cancer, PET/CT Imaging +1

Start: 2022-08-16End: 2026-12-31Target: 90Updated: 2024-07-05

Phase 1

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

RecruitingNCT07660406

Peking Union Medical College HospitalKeloid

Start: 2024-08-01End: 2027-10-01Target: 30Updated: 2026-06-22

Related Papers

Abstract P2-07-14: Head-to-head comparison of the dual-targeting tracer [68Ga]Ga-RM26-RGD and [18F]FDG for PET imaging of breast cancer

Clinical Cancer Research2025-06-13